Zhejiang Tasln Biopharma Co.,Ltd

Tirzepatide API

CAS No.: 2023788-19-2
Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈
Molecular Weight: ~4,813.45 g/mol
Purity: ≥98% (≥99% available)
Grade: Pharmaceutical Grade
Storage: -20°C, dry, protected from light
Shelf Life: 24 months
GMP Compliance: cGMP
DMF Status: US DMF available

Product Description

Tirzepatide is a first-in-class dual agonist targeting GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors. It combines the effects of both incretin hormones to enhance insulin secretion and reduce appetite. The C20 fatty diacid side chain enables high albumin binding and a half-life of approximately 5 days, supporting once-weekly administration.

Key Features

• Dual GIP/GLP-1 receptor agonist

• Once-weekly dosing

• HbA1c reduction: 1.5-2.0%

• Weight loss: 15-21% at 72 weeks

• cGMP manufacturing

• US DMF available

Applications

• Type 2 diabetes research

• Weight management

• Metabolic disorder studies

Why Choose Us

• 20 years peptide experience

• cGMP certified

• US DMF support

• ≥98-99% purity

• Reliable global supply

Packaging & Storage

Parameter	Condition
Storage	-20°C, dry, protected from light
Shelf Life	24 months
Shipping	Temperature-controlled

Documentation

COA, stability data, GMP statement, DMF

Contact Us

For pricing, DMF, or samples, please contact our sales team.